Within the government reimbursement program "Affordable Medicines", based on the results of consideration of applications of manufacturers, which were accepted from January 2nd, 2018 to January 11th, 2018, Order of the Ministry of Health of Ukraine No. 111 as of January 22nd, 2018 approved an updated Register of Medicines Subject to Reimbursement.
The Register contains 239 items of medicines for the treatment of cardiovascular diseases, diabetes of type II and bronchial asthma, which is 41 more than in the previous one.
Therefore Order of the Ministry of Health of Ukraine No. 856 as of July 26th, 2017 has expired.
The updated Register of Medicines Subject to Reimbursement has been approved taking into account the following:
On December 27th, 2017 the Government adopted changes to the "Affordable Medicines" program, supplementing it with two new active substances for the treatment of cardiovascular diseases and diabetes of type 2 - Lozartan and Glibenclamide.
Order of the Ministry of Health of Ukraine No. 2 as of January 2nd, 2018 approved a new register of ex-factory prices for medicines.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
